InvestSMART

Invion Limited (ASX: IVX) - Announcements

- Current share price for IVX : $0.034

ASX company news and announcements for Invion Limited (IVX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invion Limited (IVX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invion Limited (IVX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invion Limited (IVX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$4 Ethics Approval for Phase I/II Non-Meloma Skin Cancer Trial 11 Sep 2024 8:40AM $0.002 $0.034 risen by 1,600%
$4 Change of Director's Interest Notice - Alan Yamashita 9 Sep 2024 9:10AM $0.002 $0.034 risen by 1,600%
$4 Change of Director's Interest Notice- Thian Chew 9 Sep 2024 9:08AM $0.002 $0.034 risen by 1,600%
$4 Section 708A Cleansing Statement 9 Sep 2024 9:06AM $0.002 $0.034 risen by 1,600%
$4 Application for quotation of securities - IVX 9 Sep 2024 9:03AM $0.002 $0.034 risen by 1,600%
$4 Final Director's Interest Notice - Robert Merriel 4 Sep 2024 9:04AM $0.003 $0.034 risen by 1,033.33%
$4 Initial Director's Interest Notice - Melanie Leydin 4 Sep 2024 9:03AM $0.003 $0.034 risen by 1,033.33%
$4 Notification of cessation of securities - IVX 4 Sep 2024 8:59AM $0.003 $0.034 risen by 1,033.33%
$4 Appendix 4G and Corporate Governance Statement 30 Aug 2024 2:57PM $0.003 $0.034 risen by 1,033.33%
$4 Appendix 4E and Annual Report 30 Aug 2024 2:55PM $0.003 $0.034 risen by 1,033.33%
$4 Director Appointment/Resignation 29 Aug 2024 10:56AM $0.004 $0.034 risen by 750%
$4 Cleansing Statement and Excluded Information 7 Aug 2024 4:45PM $0.003 $0.034 risen by 1,260%
$4 Application for quotation of securities - IVX 7 Aug 2024 4:34PM $0.003 $0.034 risen by 1,260%
$4 Change of Company Secretary 31 Jul 2024 9:03AM $0.004 $0.034 risen by 871.43%
$4 Activities Report and Appendix 4C 30 Jul 2024 2:08PM $0.004 $0.034 risen by 750%
$4 Notification of cessation of securities - IVX 1 Jul 2024 11:01AM $0.004 $0.034 risen by 750%
$4 Change of Share Registry 1 Jul 2024 10:01AM $0.004 $0.034 risen by 750%
$4 Notification regarding unquoted securities - IVX 1 Jul 2024 8:21AM $0.004 $0.034 risen by 750%
$4 Section 708A Cleansing Statement 28 Jun 2024 6:29PM $0.004 $0.034 risen by 750%
$4 Application for quotation of securities - IVX 28 Jun 2024 6:25PM $0.004 $0.034 risen by 750%
$4 Proposed issue of securities - IVX 28 Jun 2024 8:22AM $0.005 $0.034 risen by 580%
$4 Invion secures funding through an institutional placement 28 Jun 2024 8:21AM $0.005 $0.034 risen by 580%
$4 Change in substantial holding 7 Jun 2024 1:31PM $0.005 $0.034 risen by 655.56%
$4 Agreement with Major South Korean Pharma Group Hanlim 8 May 2024 9:16AM $0.005 $0.034 risen by 580%
$4 Activities Report and Appendix 4C 30 Apr 2024 1:12PM $0.005 $0.034 risen by 580%

176 - 200 of 731 results

Page 8 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.